首页> 美国卫生研究院文献>BioMed Research International >Collagen External Scaffolds Mitigate Intimal Hyperplasia and Improve Remodeling of Vein Grafts in a Rabbit Arteriovenous Graft Model
【2h】

Collagen External Scaffolds Mitigate Intimal Hyperplasia and Improve Remodeling of Vein Grafts in a Rabbit Arteriovenous Graft Model

机译:胶原外支架减轻内膜增生并改善兔动静脉移植模型中静脉移植的重塑

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. The aim of this study was to test the effects of collagen external scaffold (CES) in intimal hyperplasia of vein grafts and explore its underlying mechanisms. Methods. Thirty-six New Zealand white rabbits were randomized into no-graft group, graft group, and CES group. The rabbit arteriovenous graft model was established. In CES group, the vein graft was wrapped around with CES. The hemodynamic parameters of vein grafts were measured intraoperatively and 4 weeks after operation by ultrasonic examination. Histological characteristics of vein grafts were also evaluated 4 weeks later. The mRNA and protein levels of proliferating cell nuclear antigen (PCNA), active cleaved-caspase-3 (ClvCasp-3), and smooth muscle 22 alpha (SM22α) were measured 4 weeks later by quantitative real-time PCR and western blot. Results. CES significantly improved the hemodynamic stability of vein grafts, with higher blood velocity and blood flow. Similarly, CES also markedly mitigated intimal hyperplasia and inhibited dilatation of vein grafts. In CES group, the upexpression of PCNA and ClvCasp-3 and the downexpression of SM22α were inhibited. Conclusion. CES exerts beneficial effects in mitigating intimal hyperplasia and improving remodeling of autogenous vein grafts, which may be associated with reducing the proliferation and apoptosis and preserving the phenotype of VSMCs.
机译:目标。这项研究的目的是测试胶原外支架(CES)在静脉内膜增生中的作用,并探讨其潜在机制。方法。将36只新西兰白兔随机分为无移植组,移植组和CES组。建立了兔动静脉移植物模型。在CES组,静脉移植物被CES包裹。在术中和术后4周通过超声检查测量静脉移植物的血液动力学参数。 4周后还评估了静脉移植物的组织学特征。 4周后,通过实时定量PCR和蛋白质印迹法检测了增殖细胞核抗原(PCNA),活性裂解的半胱天冬酶3(ClvCasp-3)和平滑肌22α(SM22α)的mRNA和蛋白质水平。结果。 CES显着提高了静脉移植物的血液动力学稳定性,并具有更高的血流速度和血流量。同样,CES还显着减轻了内膜增生并抑制了静脉移植物的扩张。 CES组抑制PCNA和ClvCasp-3的表达,抑制SM22α的表达。结论。 CES在减轻内膜增生和改善自体静脉移植物的重塑中发挥有益作用,这可能与减少VSMC的增殖和凋亡以及保留VSMC的表型有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号